SUSAN MACDOWELL: Open Payments
NPI 1306170352 · LINCOLN CITY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 38 payments from 19 companies in 2025. Trend: 2023 $1,348 · 2024 $2,361 · 2025 $988
Food & beverage: $889Education: $99
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 6 | $173 |
| AstraZeneca Pharmaceuticals LP | 5 | $140 |
| SEAGEN INC. | 1 | $99 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| PFIZER INC. | 3 | $69 |
| Incyte Corporation | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| JAZZ PHARMACEUTICALS INC. | 2 | $42 |
| ARRAY BIOPHARMA INC | 2 | $42 |
| EMD Serono, Inc. | 2 | $38 |
Products named: REBLOZYL, KEYTRUDA, MONJUVI, IMFINZI, CALQUENCE, BRAFTOVI, ENHERTU, Vonjo.
Industry payments across OR — which companies pay providers there.
